ライフサイエンスコーパス: dialyzer

1 e of dialysis and to a low-flux or high-flux dialyzer.

2 and 5th, 10th, 15th, and 20th reuse of each dialyzer.

3 atments with a single T220L dialyzer or F80B dialyzer.

4 lysulfone dialyzers but not with polynephron dialyzers.

5 n hospital-based facilities not reprocessing dialyzers.

6 among hospital-based facilities reprocessing dialyzers.

7 in freestanding facilities not reprocessing dialyzers.

8 ith new or reprocessed high-flux polysulfone dialyzers.

9 single use) or reprocessed (reuse) cellulose dialyzers.

10 n dialyzers and were switched to polysulfone dialyzers.

11 e not reduced by higher dose or by high flux dialyzers.

12 was undetectable in the dialysate with T220L dialyzers.

13 inical dialysis, especially with reprocessed dialyzers.

14 cellulose-tri-acetate (CTA), and polysulfone dialyzers.

15 (P < 0.05) than that observed with cellulose dialyzers.

16 tically significant (P < 0.05) for all three dialyzers.

17 s dialyzed with new or reprocessed cellulose dialyzers.

18 ymptomatic hypotension in patients on reused dialyzers (11 +/- 3) compared with patients on single-us

19 e dialyzers and were switched to polynephron dialyzers; 41 patients started on polynephron dialyzers

20 ions over 10 days) with either a high-cutoff dialyzer (46 patients) or a conventional high-flux dialy

21 er (46 patients) or a conventional high-flux dialyzer (48 patients).

22 +/- 3) compared with patients on single-use dialyzers (8 +/- 2).

23 taraldehyde and bleach-reprocessed cellulose dialyzers after random assignment to 12 wk of dialysis w

24 With F80B dialyzers, albumin was detected in the dialysate in four

25 e exposed to 11.5-year-old cellulose acetate dialyzers (all of these dialyzers were discarded by the

26 tended hemodialysis with the Gambro HCO 1100 dialyzer allowed continuous, safe removal of FLC in larg

27 osure to aged cellulose acetate membranes of dialyzers, allowing cellulose acetate degradation produc

28 ly, with reuse, creatinine clearance of F80B dialyzers also decreased at Qb 300 (P = 0.07) and Qb 400

29 tain the required parts, (ii) assembling the dialyzer and (iii) sealing the dialyzer with epoxy.

30 were no significant differences between new dialyzers and dialyzers reprocessed once.

31 eek hemodialysis to either high- or low-flux dialyzers and either ultrapure or standard dialysate usi

32 dialysis: 28 patients started on polysulfone dialyzers and were switched to polynephron dialyzers; 41

33 ialyzers; 41 patients started on polynephron dialyzers and were switched to polysulfone dialyzers.

34 tively, with cellulose, CTA, and polysulfone dialyzers, and postdialysis levels were 17,834 +/- 861,

35 ignificantly different from that of new F80B dialyzers at either Qb.

36 Urea clearance of F80B dialyzers at Qb 300 decreased from 241 +/- 2 ml/min for

37 ve predialysis serum beta(2)M levels but not dialyzer beta(2)M clearance were associated with all-cau

38 baseline residual kidney urea clearance and dialyzer beta(2)M clearance were strong predictors of pr

39 the associations of serum beta(2)M levels or dialyzer beta(2)M clearance with mortality.

40 In conclusion, dialyzer BPA content may contribute to BPA burden in pat

41 er one hemodialysis session with polysulfone dialyzers but not with polynephron dialyzers.

42 n clearance of F80B was < 5.0 ml/min for new dialyzers, but increased to 21.2 +/- 5.3 ml/min (Qb 300)

43 clearance or by binding to materials in the dialyzer circuit.

44 ex) is either bound or removed from blood by dialyzer circuits.

45 ficant removal of the drug from the blood by dialyzer clearance or by binding to materials in the dia

46 mphasize the greater need for information on dialyzer clearances during clinical dialysis, especially

47 20, and 225 +/- 32 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers rep

48 11, and 270 +/- 35 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers rep

49 35, and 427 +/- 67 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers rep

50 0, and 213 +/- 22 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers rep

51 trast, urea or creatinine clearance of T220L dialyzers did not decrease with reuse at either Qb.

52 Chronic (3-month) use of polysulfone dialyzers did not significantly increase predialysis ser

53 from Amicon-20 Diafilters or Fresenius F-80 dialyzers during continuous venovenous hemofiltration (C

54 mpliance, vascular access recirculation, and dialyzer dysfunction.

55 The study utilized five different dialyzers, each with a widely varying membrane type, and

56 ot significantly different between the three dialyzers either predialysis (P = 0.28) or postdialysis

57 The dialyzers evaluated contained either modified cellulosic

58 We previously used the dialyzer for small-volume non-enzymatic RNA synthesis re

59 after chronic hemodialysis with polysulfone dialyzers (from 0.039+/-0.002 to 0.043+/-0.001 ng/10(6)

60 lls, P<0.01), but decreased with polynephron dialyzers (from 0.045+/-0.001 to 0.036+/-0.001 ng/10(6)

61 Hemodialysis with reprocessed dialyzers has been associated with an increased mortalit

62 in the United States, performance of reused dialyzers has not been extensively and critically evalua

63 reprocessed high-efficiency and "high-flux" dialyzers has raised concerns about the increased risk o

64 rmore, chronic hemodialysis with polysulfone dialyzers increased oxidative stress in PBMCs and inflam

65 Pre-dialyzer infusion of PBUT binding competitors into the b

66 The liposome dialyzer is a small-volume equilibrium dialysis device,

67 The dialyzer is prepared by modification of commercially ava

68 The dialyzer is prepared in three stages: (i) disassembling

69 Because adsorptive capacity of hollow-fiber dialyzers is limited, we sought to determine whether hem

70 ong the several disadvantages of reprocessed dialyzers is the concern that reuse could decrease the c

71 nd test solute is improved by increasing the dialyzer mass transfer area coefficient (KoA) and the di

72 ystem 3 hemodialysis machine; Fresenius F80B dialyzer; median blood flow rate 400 ml/min; dialysate f

73 ose of dialysis and the level of flux of the dialyzer membrane on mortality and morbidity among patie

74 In this study, surfaces of polymeric dialyzer membranes, consisting of polysulfone (PS) and p

75 tocrit monitoring and improved biocompatible dialyzer membranes.

76 toxins and decreases their diffusion across dialyzer membranes.

77 (1) a three-compartment patient model, (2) a dialyzer model.

78 ation of field-retrieved 0- to 13.6-year-old dialyzers of similar type indicated significant chemical

79 ntaining polysulfone or BPA-free polynephron dialyzers on BPA levels in 69 prevalent patients on hemo

80 o 21 dialysis treatments with a single T220L dialyzer or F80B dialyzer.

81 ircuit with either new high-flux polysulfone dialyzers or dialyzers reprocessed once or 20 times with

82 in free-standing facilities not reprocessing dialyzers or in those reprocessing with formaldehyde.

83 igher than predialysis levels with all three dialyzers (P < 0.05).

84 were statistically significant for all three dialyzers (P < 0.05).

85 in predialysis BPI levels between the three dialyzers (P = 0.21).

86 A more accurate knowledge of dialyzer performance in vivo would help to ensure that t

87 With improved dialyzer performance, removal of strongly bound PBUTs im

88 od line tubing directly or indirectly during dialyzer priming and tubing assembly.

89 han treatment in facilities not reprocessing dialyzers (rate ratio [RR],1.10, 95% confidence interval

90 Chronic use of polynephron dialyzers reduced predialysis serum BPA (from 70.6+/-8.4

91 w dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20 times (P = 0.004).

92 w dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20 times (P = 0.006).

93 w dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20 times (P = 0.008).

94 w dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20 times (P = 0.20).

95 IL-1 alpha production by PBMC from dialyzers reprocessed 20 times was significantly greater

96 ither new high-flux polysulfone dialyzers or dialyzers reprocessed once or 20 times with formaldehyde

97 +/- 32 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20

98 +/- 35 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20

99 +/- 67 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20

100 +/- 22 pg, respectively, for new dialyzers, dialyzers reprocessed once, and dialyzers reprocessed 20

101 was significantly greater than both new and dialyzers reprocessed once.

102 ficant differences between new dialyzers and dialyzers reprocessed once.

103 e (T220L) and "high-flux" polysulfone (F80B) dialyzers reprocessed with formaldehyde and bleach.

104 (beta2M) clearance by low-flux and high-flux dialyzers reprocessed with various germicides.

105 /- 2% and 65 +/- 2% for reuse and single-use dialyzers, respectively (not significant).

106 /- 1151% for cellulose, CTA, and polysulfone dialyzers, respectively.

107 s ratios for cellulose, CTA, and polysulfone dialyzers, respectively.

108 ialysis with cellulose, CTA, and polysulfone dialyzers results in a significant increase in LBP and B

109 Although dialyzer reuse in chronic hemodialysis patients is commo

110 During the 12-wk study, the mean number of dialyzer reuses was 7 +/- 1 in the reuse group and there

111 s and the effects of dialysate flow rate and dialyzer size on PBUT removal.

112 rd higher HD doses and use of more high-flux dialyzers, suggest the need to redetermine the dose leve

113 emodialysis was performed with a custom-made dialyzer (surface area 150 cm2) against a bicarbonate-bu

114 Preparation of the dialyzer takes approximately 1.5 h, not including overni

115 This dialyzer then was evaluated in eight patients with myelo

116 300 decreased from 241 +/- 2 ml/min for new dialyzers to 221 +/- 5 ml/min after 20 reuses (P < 0.001

117 1), and Qb 400 from 280 +/- 4 ml/min for new dialyzers to 253 +/- 7 ml/min after 20 reuses (P = 0.001

118 a conventional hemodialysis device bearing a dialyzer, two pumps and connecting tubes, to build a rou

119 Among freestanding facilities reprocessing dialyzers, use of peracetic/acetic acid was associated w

120 earance of PPi by a 2.1-m2 cellulose acetate dialyzer was 36%, and the mean PPi removal in five patie

121 o studies indicated that the Gambro HCO 1100 dialyzer was the most efficient of seven tested.

122 extended hemodialysis with a protein-leaking dialyzer was used.

123 Beta 2 microglobulin clearance of T220L dialyzers was < 5.0 ml/min across the reuses studied.

124 Urea or creatinine clearance of new T220L dialyzers was not significantly different from that of n

125 Urea clearance of T220L dialyzers was significantly higher than that of F80B at

126 ld cellulose acetate dialyzers (all of these dialyzers were discarded by the hospital before our inve

127 and hospital-based units that did not reuse dialyzers were not significantly different from each oth

128 g/mL) and polysulfone (10.73 +/- 2.24 ng/mL) dialyzers were significantly greater (P < 0.05) than tha

129 ssembling the dialyzer and (iii) sealing the dialyzer with epoxy.

130 e that reprocessing of high-flux polysulfone dialyzers with bleach increases the risk of reverse-tran

131 ival in freestanding facilities reprocessing dialyzers with either formaldehyde (RR,1.03, 95% CI, 0.9

132 al in hospital-based facilities reprocessing dialyzers with either peracetic/acetic acid (RR=0.95, 95

133 s suggest that the reprocessing of cellulose dialyzers with glutaraldehyde and bleach does not affect

134 ysis in freestanding facilities reprocessing dialyzers with peracetic/acetic acid may be associated w

135 ysis in freestanding facilities reprocessing dialyzers with the combination of peracetic and acetic a

136 in light chains) or a conventional high-flux dialyzer (with small pores and lower permeability).

137 reated with hemodialysis using a high-cutoff dialyzer (with very large membrane pores and high permea